Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  Smith & Nephew Plc    SN.   GB0009223206

SMITH & NEPHEW PLC

(SN.)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed London Stock Exchange
10/13/2020 10/14/2020 10/15/2020 10/16/2020 10/19/2020 Date
1527(c) 1508.5(c) 1483.5(c) 1505.5(c) 1490.5(c) Last
1 197 143 1 424 420 1 427 046 1 194 413 1 272 308 Volume
-0.33% -1.21% -1.66% +1.48% -1.00% Change
More quotes
Financials (USD)
Sales 2020 4 686 M - -
Net income 2020 401 M - -
Net Debt 2020 1 646 M - -
P/E ratio 2020 43,9x
Yield 2020 1,48%
Sales 2021 5 329 M - -
Net income 2021 710 M - -
Net Debt 2021 1 253 M - -
P/E ratio 2021 23,7x
Yield 2021 1,98%
Capitalization 16 991 M 16 995 M -
EV / Sales 2020 3,98x
EV / Sales 2021 3,42x
Nbr of Employees 17 500
Free-Float 98,7%
More Financials
Company
Smith & Nephew Plc specializes in designing, manufacturing and marketing medical products and equipments. Net sales break down by activity sector as follows: - specialized surgery (73.1%): orthopedics (primarily orthopedic implants ; hips, knees and shoulders) and endoscopy (surgery and damaged tissue repair products, visualization products, etc.); - wound care (26.9%): skin grafts for major burns victims,... 
More about the company
Notations Surperformance© of Smith & Nephew Plc
Trading Rating : Investor Rating :
More Ratings
All news about SMITH & NEPHEW PLC
10/13U.S. Supreme Court to hear challenge to influential patent court
RE
10/13SMITH & NEPHEW : U.S. Supreme Court to hear challenge to influential patent cour..
RE
10/12SMITH & NEPHEW : Timing of Smith+Nephew Third Quarter 2020 Trading Report
AQ
10/09SMITH & NEPHEW : Timing of Smith+Nephew Third Quarter 2020 Trading Report
PU
10/065 Long Term Incentive Plans Overwhelmingly Voted By Investors
AQ
10/02SMITH & NEPHEW : +Nephew update on third quarter trading
AQ
10/01SMITH & NEPHEW : +Nephew update on third quarter trading
PU
10/01SMITH & NEPHEW : revenue slide to slow in third quarter
RE
10/01SMITH & NEPHEW : Expects 3Q Underlying Revenue to Fall 4%
DJ
10/01SMITH & NEPHEW PLC : Ex-dividend day for interim dividend
FA
09/30SMITH & NEPHEW : +Nephew expands in higher-growth extremities segment through pl..
AQ
09/29SMITH & NEPHEW : Buys Extremity Orthopedics for $240 Million
DJ
09/29Smith & Nephew Plc Extremities Acquisition
DJ
09/29SMITH & NEPHEW : +Nephew expands in higher-growth extremities segment through pl..
PU
09/29SMITH & NEPHEW : Integra LifeSciences Announces Definitive Agreement to Divest i..
AQ
More news
News in other languages on SMITH & NEPHEW PLC
04/30SMITH & NEPHEW PLC : Veröffentlichung des Quartalsumsatzes
04/30SMITH & NEPHEW PLC : publication du chiffre d'affaires trimestriel
02/20SMITH & NEPHEW PLC : prudent vis-à-vis du coronavirus
02/20Les investisseurs renouent avec la prudence face au coronavirus
01/23SMITH & NEPHEW : Eine neu veröffentlichte multizentrische RCT zeigt, dass Smith+..
More news
Analyst Recommendations on SMITH & NEPHEW PLC
More recommendations
Chart SMITH & NEPHEW PLC
Duration : Period :
Smith & Nephew Plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SMITH & NEPHEW PLC
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 15
Average target price 23,09 $
Last Close Price 19,44 $
Spread / Highest target 45,1%
Spread / Average Target 18,8%
Spread / Lowest Target -1,78%
EPS Revisions
Managers
NameTitle
Roland D. Diggelmann Chief Executive Officer & Non-Executive Director
Roberto Quarta Chairman
Mark Gladwell President-Global Operations & Business Services
Anne-Francoise Nesmes Chief Financial Officer & Executive Director
Vasant Padmanabhan President-Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
SMITH & NEPHEW PLC-17.84%16 995
STRYKER CORPORATION6.72%84 154
VENUS MEDTECH (HANGZHOU) INC.126.53%4 636
WRIGHT MEDICAL GROUP N.V.0.39%3 968
INSPIRE MEDICAL SYSTEMS, INC.70.79%3 397
AK MEDICAL HOLDINGS LIMITED159.68%3 279